Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Change in Accured Expenses (2024 - 2025)

Historic Change in Accured Expenses for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to $1.3 million.

  • Pyxis Oncology's Change in Accured Expenses fell 6728.83% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.1 million, marking a year-over-year change of. This contributed to the annual value of -$1.7 million for FY2024, which is 8815.35% up from last year.
  • Per Pyxis Oncology's latest filing, its Change in Accured Expenses stood at $1.3 million for Q3 2025, which was down 6728.83% from -$3.4 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Change in Accured Expenses ranged from a high of $4.0 million in Q3 2024 and a low of -$3.4 million during Q2 2025